Sardu, C., Paolisso, P., Sacra, C., Santamaria, M., de Lucia, C., Ruocco, A., . . . Marfella, R. (2018). Cardiac resynchronization therapy with a defibrillator (CRTd) in failing heart patients with type 2 diabetes mellitus and treated by glucagon-like peptide 1 receptor agonists (GLP-1 RA) therapy vs. conventional hypoglycemic drugs: Arrhythmic burden, hospitalizations for heart failure, and CRTd responders rate. Cardiovasc Diabetol.
Styl ChicagoSardu, Celestino, et al. "Cardiac Resynchronization Therapy With a Defibrillator (CRTd) in Failing Heart Patients With Type 2 Diabetes Mellitus and Treated By Glucagon-like Peptide 1 Receptor Agonists (GLP-1 RA) Therapy Vs. Conventional Hypoglycemic Drugs: Arrhythmic Burden, Hospitalizations for Heart Failure, and CRTd Responders Rate." Cardiovasc Diabetol 2018.
Citace podle MLASardu, Celestino, et al. "Cardiac Resynchronization Therapy With a Defibrillator (CRTd) in Failing Heart Patients With Type 2 Diabetes Mellitus and Treated By Glucagon-like Peptide 1 Receptor Agonists (GLP-1 RA) Therapy Vs. Conventional Hypoglycemic Drugs: Arrhythmic Burden, Hospitalizations for Heart Failure, and CRTd Responders Rate." Cardiovasc Diabetol 2018.